Cort Olsen
Former associate editorOlsen is a former associate editor of Employee Benefit Adviser.
Olsen is a former associate editor of Employee Benefit Adviser.
While cryptocurrencies like Bitcoin and Litecoin have used this technology for several years, innovators in the group healthcare market are exploring ways to use this data security provision to monitor claims cost.
Deals dipped slightly compared to 2018’s first quarter; however it is not indicative of overall trend for mergers and acquisitions in North America, according OPTIS Partners’ recent M&A Database report.
The online retail giant’s purchase of the drug delivery service could mean the end of pharmacy benefit managers and a major wake up call for benefit brokers, says Shandon Fowler.
Pharmacy benefit manager rebates and third-party revenues are killing employer’s prescription drug plans. What are the best strategies to adopt?
The online retail giant’s purchase of the drug delivery service could mean the end of pharmacy benefit managers and a major wake up call for benefit brokers, says Shandon Fowler.
Health savings account participants are more engaged in their healthcare decisions but still see HSAs as ways for reducing medical expense.
An advertisement by Blue Cross Blue Shield of North Carolina has sparked debate among advisers nationwide, leaving them to ask who is really paying the broker and is anyone on the side of the employer.
Injectable drugs and in-patient care drive the highest of cost for employers.
Injectable drugs and in-patient care drive the highest of cost for employers.
In an effort to bring insurance carriers back to ACA exchanges, the U.S. government is increasing funding to insurers, which could spur brokers to recommend the exchanges to clients.